H Y Wong, C H Chau, W W Yew. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Aged, 80 and overAntitubercular Agents/administration & dosageAntitubercular Agents/adverse effectsArthritis/chemically inducedAza Compounds/administration & dosageDrug Therapy, CombinationFluoroquinolonesHumansIsoniazid/administration & dosageMaleMoxifloxacinPyrazinamide/administration & dosageQuinolines/administration & dosageRifampin/administration & dosageTuberculosis, Pulmonary/drug therapy
Substances： See more » Antitubercular AgentsAza CompoundsFluoroquinolonesQuinolinesPyrazinamideMoxifloxacinIsoniazidRifampin
Year: 2007 PMID： 17217142
Source DB: PubMed Journal: Int J Tuberc Lung Dis ISSN： 1027-3719 Impact factor: 2.373